Patricia M Seraphim Selected Research

NF-kappa B p50 Subunit

1/2018

Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia M Seraphim Research Topics

Disease

2	Insulin Resistance 01/2018 - 10/2003
1	Inflammation (Inflammations) 08/2020
1	Wounds and Injuries (Trauma) 08/2020
1	Body Weight (Weight, Body) 10/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 08/2020 - 10/2003
2	Messenger RNA (mRNA)IBA 01/2018 - 10/2003
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2003
1	EnzymesIBA 08/2020
1	Metalloproteases (Metalloproteinases)IBA 08/2020
1	AntioxidantsIBA 08/2020
1	Acetates (Acetic Acid Esters)FDA Link 08/2020
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2018
1	AlbuminsIBA 01/2018
1	NF-kappa B p50 SubunitIBA 01/2018
1	Glucose Transporter Type 4IBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	Insulin (Novolin)FDA Link 10/2003
1	MelatoninIBA 10/2003

Therapy/Procedure

1	Pinealectomy 10/2003